Kathryn McNaughton
VP, Program Strategy & Management @ Astria Therapeutics, Inc.
About
I am a biopharma executive with more than 20 years of experience in the industry, including a sustained focus on building, scaling, and leading enterprise‑level program leadership and program management organizations across the drug development lifecycle, from discovery research through launch and life-cycle planning. My experience spans rare disease, immunology, oncology, and CNS therapeutic areas, where I have advanced biologics, gene therapies, and small molecules through complex development and regulatory pathways. I am driven by helping companies translate scientific innovation into patient impact by shaping development strategies and building sustainable organizational capabilities that enable disciplined execution and long-term value creation.
United States
Needham
Biotechnology
Biotechnology, Drug Development, Clinical Development, Biopharmaceuticals, Pharmaceutical Industry, Cross-functional Team Leadership, Program Management, Clinical Trials, FDA, Regulatory Affairs, Drug Discovery, Business Development, Regulatory Submissions, Technology Transfer, Lifesciences, R&D, GLP, Oncology, Project Management, Quality Assurance
Experience
VP, Program Strategy & Management
Astria Therapeutics, Inc.
As VP of Program Strategy and Management at Astria Therapeutics, I built and led the program leadership and management function, establishing the framework and leadership required for cross‑functional strategy and execution across the portfolio. Concurrently, as Program Leader for navenibart in hereditary angioedema, I led the cross‑functional program team in defining the global registration strategy for navenibart and drove enterprise readiness for late‑stage development, enabling successful regulatory engagement and global Phase 3 execution.
SVP, Portfolio & Program Management
Dunad Therapeutics
Cambridge, MA
President
McNaughton Pharmaceutical Consulting, L.L.C.
Greater Boston Area
Program and Portfolio Strategy, and Operations Management Leadership
SVP, Portfolio and Program Management
AVROBIO
Cambridge, MA
As a member of the Executive Team, helped build AVROBIO from a small, privately-held, preclinical-stage company to a public company with a leading lysosomal disorder gene therapy pipeline including multiple clinical-stage programs. Head of the Pipeline Steering Committee and responsible for leadership of AVROBIO's development pipeline of gene therapy programs. Interim Head of Regulatory Affairs.
President
McNaughton Pharmaceutical Consulting, L.L.C.
Greater Boston Area
Program and Portfolio Strategy, and Operations Management Leadership
Vice President, R&D Pipeline Program Management
Synageva BioPharma Corp.
Lexington, MA
Responsible for leadership of Synageva's Research and early Development pipeline of rare disease therapeutics programs.
Senior Director, Head of Program Managers
Shire
Lexington, MA
Built and led a high-performing program management function supporting Development Teams across all commercial products and pipeline development programs in Shire’s Rare Diseases Business Unit.
Program Executive, Senior Director, Program Management
Shire
Lexington, MA
Led cross-functional teams to develop product strategies and execute program plans for multiple orphan drug development programs. Led a team that successfully developed VPRIV from phase I through launch for the treatment of Gaucher disease. Demonstrated strong leadership of diligence teams in the evaluation of business development opportunities.
Associate Director, Program Management
Praecis Pharmaceuticals
Waltham, MA
Managed cross-functional teams to develop program strategy and fulfill project goals. Established project plans for the Alzheimer’s disease therapeutics program from phase I through NDA and for Plenaxis phase IV commitments.
Senior Scientist
Praecis Pharmaceuticals
Waltham & Cambridge, MA
Designed, synthesized, and formulated peptide-based therapeutics for multiple R&D programs. Co-discovered Apan (IND filed in 2000), a drug candidate for the treatment of Alzheimer’s disease. Supervised research associates.
Assistant Professor / Adjunct Faculty
Wentworth Institute of Technology
Boston, MA
Taught chemistry, physics and algebra, and served as an advisor to the Society of Women Engineers.
Education
Princeton University
Chemistry
Monmouth University
Chemistry
Kathryn McNaughton's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.